ACE inhibitors and pneumonia
Clicks: 254
ID: 272713
1998
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
254 views
40 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #107 of 161 articles by views in Lancet (London, England)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 161 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
ACE inhibitors and pneumonia
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (4 words).
Try re-searching for a better abstract.
| Reference Key |
k1998lancetace
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Sekizawa K;Matsui T;Nakagawa T;Nakayama K;Sasaki H;; |
| Journal | Lancet (London, England) |
| Year | 1998 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
aged
Prospective Studies
comment
pneumonia / etiology
letter
k sekizawa
h sasaki
angiotensin-converting enzyme inhibitors / therapeutic use*
pneumonia / prevention & control*
pmid:9759784
doi:10.1016/s0140-6736(05)60114-6
t matsui
antihypertensive agents / therapeutic use
cerebrovascular disorders / complications
cerebrovascular disorders / drug therapy*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.